Heteroresistance to amikacin in Klebsiella aerogenes isolates from patients in an intensive care unit in Brazil
Microbiology Spectrum · 07.04.2026 · 14 (4)
DOI: 10.1128/spectrum.02833-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 07.04.2026. Verfasst von Natália Ribeiro Crispim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, São Paulo, Brazil. Hauptthemen laut MEDLINE: Amikacin, Anti-Bacterial Agents, Enterobacter aerogenes, Klebsiella Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Korea National Institute of Health, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Themen: Intensivpflege
Abstract (Originalsprache)
Heteroresistance is defined by the presence of subpopulations within a bacterial isolate that exhibit greater antibiotic resistance than the dominant population. In this study, we investigated amikacin heteroresistance in the opportunistic, nosocomial pathogen Klebsiella aerogenes (AHR-KA). Eight carbapenemase-resistant, but amikacin-susceptible, isolates from intensive care units of a Brazilian hospital were analyzed. Population analysis profiling identified five amikacin heteroresistant isolates (AHR-KA-1 to 5), with subpopulation frequencies ranging from 1.83 × 10 −7 to 6.01 × 10 −6 . Among these, only AHR-KA-1 exhibited stable heteroresistance following serial passaging in antibiotic-free media. AHR-KA-1 demonstrated only slightly reduced growth rates when compared with those of the unstable AHR-KAs, parental, and control strains, suggesting no significant fitness cost associated with drug resistance. Time-kill assays for AHR-KA-1 showed an initial decline in cell viability, followed by regrowth at both 4× and 8× MIC. The draft genome of the stable isolate had a total length and G+C content similar to most of the sequenced genomes from K. aerogenes . Notably, AHR-KA-1′s aac(6 ′ )-Ib-cr variant contained D179Y and R102W mutations, conferring amikacin resistance. Moreover, quantitative reverse transcription PCR revealed significantly elevated expression of the aac(6 ′ )-Ib-cr gene in AHR-KA-1 before amikacin-free passage, compared to both the parental strain and the AHR-KA-1 strain after drug-free passage. Therefore, this study identified amikacin heteroresistance in carbapenemase-producing K. aerogenes , including a stable, mutation-driven phenotype with low fitness cost and rapid regrowth under high amikacin concentrations, underscoring its clinical relevance. These findings reinforce the importance of detecting heteroresistant subpopulations and strengthening surveillance to prevent treatment failure and the spread of undetected resistance. IMPORTANCE Klebsiella aerogenes , an opportunistic human pathogen, is frequently implicated in severe and invasive infections, particularly in immunocompromised individuals. The growing prevalence of antibiotic resistance among these strains poses a significant therapeutic challenge. The phenomenon of heteroresistance further complicates management, potentially leading to diagnostic difficulties due to the lack of standardized detection methods and subsequent treatment failures. Our studies identified and characterized K. aerogenes strains heteroresistant to amikacin, isolated from patients in an intensive care unit. Such data can serve as a foundational reference for understanding the clinical relevance, genomic variability, and pathogenic potential of K. aerogenes heteroresistance to antibiotics used in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Genética e Evolução, Universidade Federal de São Carlos, São Carlos, São Paulo, Brazil.
- Laboratório Central de Saúde Pública do Tocantins, Palmas, Tocantins, Brazil.
- Programas de Pós-graduação em Odontologia, Biotecnologia e Tecnologia Ambiental, Universidade de Ribeirão Preto, Ribeirao Preto, Brazil.
- Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan, South Korea.
ORCID-Profile: Natália Ribeiro Crispim, Robert J Mitchell, Maria-Cristina da Silva Pranchevicius
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Korea National Institute of Health
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Crispim, N. R., Nunes, G. D., Soares, G. G., Shilling, R. E., Ferreira, R. L., Campos, L. C., Alcobaça, O. S. A., Silva, J. P. M. O., Rodrigues, S. H., Pitondo-Silva, A., Fuentes, A. S. C., Cunha, A. F., Mitchell, R. J., & Pranchevicius, M. C. S. (2026). Heteroresistance to amikacin in Klebsiella aerogenes isolates from patients in an intensive care unit in Brazil. Microbiology Spectrum, 14(4). https://doi.org/10.1128/spectrum.02833-25
Vancouver
Crispim NR, Nunes GD, Soares GG, Shilling RE, Ferreira RL, Campos LC, et al. Heteroresistance to amikacin in Klebsiella aerogenes isolates from patients in an intensive care unit in Brazil. Microbiology Spectrum. 2026;14(4). doi:10.1128/spectrum.02833-25
BibTeX
@article{Crispim2026,
author = {Crispim, Natália Ribeiro and Nunes, Gustavo Dantas and Soares, Gabriela Guerrera and Shilling, Rebecca Elizabeth and Ferreira, Roumayne Lopes and Campos, Leslie Camelo and Alcobaça, Olinda Soares Athaide and Silva, João Pedro Maia de Oliveira da and Rodrigues, Saulo Henrique and Pitondo-Silva, André and Fuentes, Andrea Soares da Costa and Cunha, Anderson Ferreira da and Mitchell, Robert J and Pranchevicius, Maria-Cristina da Silva},
title = {Heteroresistance to amikacin in Klebsiella aerogenes isolates from patients in an intensive care unit in Brazil},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {4},
doi = {10.1128/spectrum.02833-25}
}
EUVIMED